In vitro recovery of ATP-sensitive potassium channels in β-cells from patients with congenital hyperinsulinism of infancy

Diabetes

Volumn 60, Issue 4, 2011, Pages 1223-1228

  Powell, Philippa D ^a   Bellanné Chantelot, Christine ^b   Flanagan, Sarah E ^c   Ellard, Sian ^c   Rooman, Raoul ^d   Hussain, Khalid ^e   Skae, Mars ^f   Clayton, Peter ^f   De Lonlay, Pascale ^g   Dunne, Mark J ^a   Cosgrove, Karen E ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITY OF EXETER   (United Kingdom)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^f ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; DIAZOXIDE; FORSKOLIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; ISOBUTYLMETHYLXANTHINE; MYRISTIC ACID; SULFONYLUREA RECEPTOR 1;

ARTICLE; CADAVER DONOR; CONTROLLED STUDY; ELECTROPHYSIOLOGY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INSULIN RELEASE; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PATCH CLAMP; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ATP-BINDING CASSETTE TRANSPORTERS; BENZOTHIADIAZINES; CELLS, CULTURED; CHILD, PRESCHOOL; CYCLIC S-OXIDES; HUMANS; INFANT; INFANT, NEWBORN; INSULIN-SECRETING CELLS; KATP CHANNELS; MODELS, BIOLOGICAL; MUTATION; PANCREATECTOMY; PATCH-CLAMP TECHNIQUES; PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY; PHENYLBUTYRATES; PHORBOL ESTERS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG;

EID: 79953221452     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-1443     Document Type: Article

References (25)

1. Dunne MJ, Cosgrove KE, Shepherd RM, Aynsley-Green A, Lindley KJ. Hyperinsulinism in infancy: from basic science to clinical disease. Physiol Rev 2004;84:239-275 (Pubitemid 38049881)
2. Flanagan SE, Clauin S, Bellanné-Chantelot C, et al. Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 2009;30:170-180
3. Kane C, Shepherd RM, Squires PE, et al. Loss of functional KATP channels in pancreatic β-cells causes persistent hyperinsulinemic hypoglycemia of infancy. Nat Med 1996;2:1344-1347 (Pubitemid 26401737)
4. Dunne MJ, Kane C, Shepherd RM, et al. Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med 1997;336:703-706 (Pubitemid 27102685)
5. Conti LR, Radeke CM, Vandenberg CA. Membrane targeting of ATP-sensitive potassium channel. Effects of glycosylation on surface expression. J Biol Chem 2002;277:25416-25422 (Pubitemid 34951854)
6. Partridge CJ, Beech DJ, Sivaprasadarao A. Identification and pharmacological correction of a membrane trafficking defect associated with a mutation in the sulfonylurea receptor causing familial hyperinsulinism. J Biol Chem 2001;276:35947-35952
7. Shyng SL, Ferrigni T, Shepard JB, et al. Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy. Diabetes 1998;47:1145-1151 (Pubitemid 28294559)
8. Taschenberger G, Mougey A, Shen S, Lester LB, LaFranchi S, Shyng SL. Identification of a familial hyperinsulinism-causing mutation in the sulfonylurea receptor 1 that prevents normal trafficking and function of KATP channels. J Biol Chem 2002;277:17139-17146 (Pubitemid 34967746)
9. Neagoe I, Schwappach B. Pas de deux in groups of four - the biogenesis of KATP channels. J Mol Cell Cardiol 2005;38:887-894 (Pubitemid 40725936)
10. Yan FF, Lin CW, Weisiger E, Cartier EA, Taschenberger G, Shyng SL. Sulfonylureas correct trafficking defects of ATP-sensitive potassium channels caused by mutations in the sulfonylurea receptor. J Biol Chem 2004;279:11096-11105 (Pubitemid 38401602)
11. Yan FF, Casey J, Shyng SL. Sulfonylureas correct trafficking defects of disease-causing ATP-sensitive potassium channels by binding to the channel complex. J Biol Chem 2006;281:33403-33413 (Pubitemid 46043261)
12. Cosgrove KE, Antoine MH, Lee AT, et al. BPDZ 154 activates adenosine 5′- triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism. J Clin Endocrinol Metab 2002;87:4860-4868 (Pubitemid 35316316)
13. Zeitlin PL, Diener-West M, Rubenstein RC, Boyle MP, Lee CK, Brass-Ernst L. Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate. Mol Ther 2002;6:119-126 (Pubitemid 36124279)
14. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073 (Pubitemid 19231814)
15. Younger JM, Chen L, Ren HY, et al. Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell 2006;126:571-582 (Pubitemid 44163603)
16. Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 1992;358:761-764
17. Yan FF, Pratt EB, Chen PC, et al. Role of Hsp90 in biogenesis of the beta-cell ATP-sensitive potassium channel complex. Mol Biol Cell 2010;21:1945-1954
18. Rubenstein RC, Zeitlin PL. Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR. Am J Physiol Cell Physiol 2000;278:C259-C267 (Pubitemid 30131142)
19. Kagawa T, Varticovski L, Sai Y, Arias IM. Mechanism by which cAMP activates PI3-kinase and increases bile acid secretion in WIF-B9 cells. Am J Physiol Cell Physiol 2002;283:C1655-C1666 (Pubitemid 35340597)
20. van Balkom BWM, Savelkoul PJM, Markovich D, et al. The role of putative phosphorylation sites in the targeting and shuttling of the aquaporin-2 water channel. J Biol Chem 2002;277:41473-41479 (Pubitemid 35257449)
21. Lehrich RW, Aller SG, Webster P, Marino CR, Forrest JN Jr. Vasoactive intestinal peptide, forskolin, and genistein increase apical CFTR trafficking in the rectal gland of the spiny dogfish, Squalus acanthias. Acute regulation of CFTR trafficking in an intact epithelium. J Clin Invest 1998;101: 737-745 (Pubitemid 28096069)
22. Manna PT, Smith AJ, Taneja TK, Howell GJ, Lippiat JD, Sivaprasadarao A. Constitutive endocytic recycling and protein kinase C-mediated lysosomal degradation control K(ATP) channel surface density. J Biol Chem 2010; 285:5963-5973
23. Pedemonte N, Lukacs GL, Du K, et al. Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Invest 2005;115:2564-2571 (Pubitemid 41266219)
24. Cudkowicz ME, Andres PL, Macdonald SA, et al.; Northeast ALS and National VA ALS Research Consortiums. Phase 2 study of sodium phenylbutyrate in ALS. Amyotroph Lateral Scler 2009;10:99-106
25. Bellanné-Chantelot C, Saint-Martin C, Ribeiro MJ, et al. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism. J Med Genet 2010;47:752-759